Oricell Therapeutics’ $45 Million Series B1 Financing

Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal.Oricell Therapeutics Co., Ltd, a China-based innovative pharmaceutical company committed to the development of tumor cellular…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now